Chugai Pharmaceutical Co., Ltd.
F. Hoffman-La Roche’s Sales Performance for Q1 2026
F. Hoffman-La Roche announced its sales performance for January–March 2026. The parent company of Chugai Pharmaceutical, Roche Holding AG, holds 59.89% of the company’s shares.
Key Figures
- Parent Company Roche Holding AG’s Shareholding Ratio: 59.89% (Voting Rights Ratio: 61.12%)
- Period Covered: January 1, 2026 – March 31, 2026
- Publication Date: April 23, 2026
AI要約
Summary of Announcement
F. Hoffman-La Roche announced its sales performance for the first quarter from January to March 2026. Roche Holding AG, the parent company of Chugai Pharmaceutical, held 59.89% of Chugai’s outstanding shares (61.12% voting rights ratio) as of the end of December 2025. The Roche Group’s performance includes Chugai Pharmaceutical’s results for Q1 2026.
Information Provided for Investors
This document directs readers to information posted on the Roche Group’s website and does not contain individual financial figures or detailed operational results for Chugai Pharmaceutical. Investors are advised to refer to Roche Group’s disclosed materials.
Chugai Pharmaceutical Co., Ltd.
Company overview · Stock price · Financial data · All IR
